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Absolute dose rate: Comparison of results and uncertainty 
analysis of a) using a chamber calibrated in air (A-20 from 
Standard Imaging calibrated on ADCL Wisconsin, USA) 
following the AAPM TG-61 protocol, and b) using a parallel 
plate chamber calibrated in water (TM34013 from PTW 
calibrated on PTW, Germany) following the IAEA TRS-398 
protocol. 
PDD: Using the parallel plate chamber on solid water. 
Leakage: Measurements at different levels with the primary 
beam blocked 
 The Esteya includes a specially designed QA tool that is 
connected to the exit of the X-ray tube. Each treatment day 
it is mandatory to perform a QA test before the first patient 
can be treated. This tool is composed of 26 diodes placed in 
two parallel planes, which are used to evaluate the output, 
flatness and percentage dose depth curve constancy at the 
same time. After the QA plan has been irradiated, the 
equipment console automatically shows the comparison with 
the reference values. Only if results are below an established 
tolerance level, the system allows patients to be treated. In 
addition, within a monthly basis, flatness, symmetry, 
penumbra, output and PDD are evaluated with film or high 
resolution array and parallel plate chamber on solid water. 
 Finally, the following clinical implementation aspects will be 
presented and discussed: depth evaluation (using High 
Frequency Ultrasound), margins and applicator selection, 
patient marking, patient set-up and treatment time 
calculation. 
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Background/Objective: Low and medium energy (kV) x-ray 
radiotherapy beams are still widely used for treatment, 
particularly for skin cancers and other relatively shallow 
lesions, and also more recently for ’electronic 
brachytherapy’ (Perez-Calatayud, this session).  Historically, 
kV beams have been used widely for radiobiology and related 
experiments, the results of which have been used to inform 
clinical radiotherapy practice, although the dosimetry has 
often been on less solid foundations than radiotherapy 
dosimetry. In the last ten years or so, since the increasingly 
wide availability of kV image guidance systems on clinical 
linacs, there has been a growing need for clear 
recommendations on kV beam dosimetry for these systems, 
where practical approaches have been developed which draw 
on both diagnostic radiology dosimetry and kV therapy beam 
dosimetry and with signficant contribution from MC modelling 
(Ding, this session).  Recently too, kV applications relevant to 
radiotherapy, in terms of supporting and developmental 
research, have included pre-clinical studies using small 
animal irradiators and microbeam methods, in both cases 
requiring small (or very small) kV beam dosimetry.  In general 
terms, the same quality standards are applicable in kV 
dosimetry as for high energy (MV) x-ray beams.  Thus, 
ideally, similar levels of precision and accuracy are required 
for treatment planning and delivery and hence similar levels 
of knowledge of beam characterisics and kV beam doses for 
both clinical and research uses, including for radiotherapy 
imaging beams.  Therefore, similar attention is necessary in 
choice of  instrumentation, experimental methods, beam 
calibration dosimetry, beam commissioning and quality 
assurance measurements, and their uncertainties.  kV beams 
should also be consisdered, as for MV beams, within the same 
general infrastructure of radiotherapy quality systems, 
clinical/quality audit and dosimetric audit.  
Overview Content: This overview considers the current 
situation in kV radiotherapy beam dosimetry and aims to 
cover: 
·       an outline of the specific requirements in kV dosimetry 
·       the instrumentation requirements for absolute and 
relative dose measurements in therapy beams 
·       the current dosimetry protocols and their similarities 
and differences, both for beam calibration protocols (in air 
and in phantom) and relative dosimetry recommendations 
·       phantoms and methods for measurements 
·       the likely uncertainties involved in methods and data 
·       the differences and similarities between dosimetry for 
kV beams when used for therapy or imaging 
·       the dosimetry methods used for kV CBCT 
·       MC in kV dosimetry, linking to Ding (this session) 
·       some comments on dosimetry needs and methods for 
novel kV applications, including  small animal systems and 
microbeams.  
Conclusions: The basis of kV dosimetry and the practical 
methods used are reasonably consistent with MV dosimetry, 
although uncertainties are typically greater.  Radiotherapy 
imaging dosimetry methods span different approaches which 
still needs further effort to  agree generally recommended 
and accepted guidelines.  Recent developments in pre-
clinical and microbeam applications have concentrated effort 
on small field kV dosimetry, which in turn also improves 
dosimetry for  standard clinical uses of kV radiotherapy 
beams.   All areas of kV beam dosimetry are benefiting 
greatly from MC modelling. 
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Introduction: The utilization of kV X-ray in image-guided 
radiotherapy (IGRT) has significantly improved the 
radiotherapy delivery accuracy and IGRT has become the new 
paradigm for patient positioning and target localization. Daily 
imaging procedures also add additional dose to the patients’ 
normal tissues. Knowledge of radiation dose resulting from a 
kV-CBCT scan and kV radiograph imaging procedures is 
important for clinicians in making informed decisions for 
treatment management and risk/benefit analysis.  
Purpose: The purpose of this presentation is  
1)      to describe the Monte Carlo simulation technique to 
generate kV beams from x-ray sources that are integrated to 
a radiotherapy treatment unit;  
2)      to show the beam characteristics of kV beams used in 
image guidance procedures;  
3)      to present the techniques to calculate dose to patients 
from kV-CBCT scans and kV radiograph imaging procedures by 
using the simulated kV beams 
4)      to give overview of Radiation dose to patients resulting 
from typical image-guided procedures 
5)      To discuss methods of managing and accounting for 
imaging guidance doses to radiotherapy patients 
Methods and Materials:  Although new model based 
calculation algorithms are being developed for model the 
radiation dose from low-energy x-ray beams, the Monte Carlo 
